Argus Investors' Counsel, Inc. Illumina, Inc. Transaction History

Argus Investors' Counsel, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 24, 2020	SELL	$209.2 - $335.53 $350,200 - $561,677	-1,674 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$288.29 - $335.49 $32,000 - $37,239	111 Added 7.1%	1,674 $555,000
Q3 2019 Oct 17, 2019	SELL	$266.84 - $378.23 $11,740 - $16,642	-44 Reduced 2.74%	1,563 $475,000
Q2 2019 Jul 10, 2019	SELL	$300.59 - $368.15 $483,048 - $591,617	-1,607 Reduced 50.0%	1,607 $592,000
Q2 2019 Jul 10, 2019	BUY	$300.59 - $368.15 $478,539 - $586,094	1,592 Added 98.15%	3,214 $1.18 Million
Q1 2019 Apr 16, 2019	SELL	$272.57 - $321.18 $1,907 - $2,248	-7 Reduced 0.43%	1,622 $504,000
Q4 2018 Feb 06, 2019	BUY	$272.46 - $366.54 $50,132 - $67,443	184 Added 12.73%	1,629 $489,000
Q3 2018 Oct 16, 2018	BUY	$279.04 - $367.06 $58,877 - $77,449	211 Added 17.1%	1,445 $0
Q2 2018 Jul 19, 2018	BUY	$228.17 - $292.07 $281,561 - $360,414	1,234 New	1,234 $345,000

968

151M

2.37M

1.41M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $14.8B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Argus Investors' Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Argus Investors' Counsel, Inc. with notifications on news.